Pregled bibliografske jedinice broj: 1038988
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross- Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross- Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia // MEDICAL SCIENCE MONITOR, 23 (2017), 489-497 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1038988 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross- Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia
Autori
Piljić Burazer, Marina ; Mladinov, Suzana ; Ćapkun, Vesna ; Kuret, Sendi ; Glavina Durdov, Merica
Izvornik
MEDICAL SCIENCE MONITOR (1643-3750) 23
(2017);
489-497
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Carcinoma, Non-small cell lung, Diagnosis, Immunohistochemistry, Pathology, Prognosis, Real-time polymerase chain reaction
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE